Genoil (GNOLF) EBIAT (2019 - 2025)
Genoil has reported EBIAT over the past 7 years, most recently at -$155119.0 for Q3 2025.
- Quarterly EBIAT fell 6.1% to -$155119.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.1 million through Sep 2025, down 56.69% year-over-year, with the annual reading at -$2.1 million for FY2024, 51.78% up from the prior year.
- EBIAT was -$155119.0 for Q3 2025 at Genoil, up from -$221743.0 in the prior quarter.
- Over five years, EBIAT peaked at $143882.0 in Q1 2024 and troughed at -$2.5 million in Q1 2022.
- The 5-year median for EBIAT is -$427717.0 (2022), against an average of -$687093.4.
- Year-over-year, EBIAT plummeted 517.03% in 2022 and then surged 105.7% in 2024.
- A 5-year view of EBIAT shows it stood at -$755601.0 in 2021, then skyrocketed by 35.03% to -$490923.0 in 2022, then plummeted by 139.08% to -$1.2 million in 2023, then tumbled by 36.93% to -$1.6 million in 2024, then skyrocketed by 90.35% to -$155119.0 in 2025.
- Per Business Quant, the three most recent readings for GNOLF's EBIAT are -$155119.0 (Q3 2025), -$221743.0 (Q2 2025), and -$154992.0 (Q1 2025).